Search bioRxiv⌕ Search

Biology subjects

Nejjari, M.

Publications and source records attributed to Nejjari, M..

2 recordsLinked to original sources

Fluorescence in situ hybridization (FISH) and detection of Bacteria and Archaea cells in fecal samples

Oligonucleotide probes have been used to detect bacteria and archaea that colonize the cattle and pig digestive system. The Fluorescent in situ hybridization (FISH) is a molecular biology technique that uses oligonucleotides of 15 to 25 nucleotides of length associated with a fluorescent molecule. In microbiology, the FISH technique utilizes probes targeting ribosomal RNA (rRNA). It is one amongst others, a staining technique that allows the identification, detection and quantification of microorganisms without prior cultivation by means of epifluorescence and confocal laser scanning microscopy (CLSM). In this study, we describe the usage of the confocal laser scanning microscopy coupled with fluorescence in situ hybridization (FISH), in order to detect and quantify of bacteria and archaea in fecal samples from cattles manure and swine slurry.

microbiology↗

Thymoquinone Inhibits BTK Expression and Phosphorylation in B-Cell Lymphoma: A Novel Plant-Derived Therapeutic Approach

Brutons tyrosine kinase (BTK) is a critical regulator of B-cell receptor (BCR) signaling and a validated therapeutic target in B-cell malignancies. Current BTK inhibitors, such as ibrutinib, have shown clinical efficacy but are associated with side effects and emerging resistance. Thymoquinone (TQ), a bioactive compound derived from Nigella sativa, has demonstrated anticancer properties across various tumor types. Here, we investigate the effects of TQ on BTK expression and phosphorylation in the Burkitt lymphoma cell line Namalwa. We show that TQ significantly reduces BTK expression and inhibits its phosphorylation at low concentrations. Using RT-qPCR, we demonstrate that TQ decreases steady-state levels of BTK mRNA. Furthermore, TQs effects are comparable to those of ibrutinib, suggesting its potential as a novel BTK inhibitor. These findings highlight TQ as a promising plant-derived therapeutic agent for B-cell malignancies, warranting further preclinical and clinical evaluation.

molecular biology↗